Delving into the Latest Updates on ASP-1948 with Synapse

Overview

Basic Info

Drug Type

Monoclonal antibody

Synonyms

ASP 1948, PTZ-329, anti-neuropilin-1 antibody ASP1948

Target

NRP-1

Mechanism

NRP-1 inhibitors(Neuropilin-1 inhibitors)

Therapeutic Areas

Neoplasms

Active Indication

Locally Advanced Malignant Solid Neoplasm

Inactive Indication-

Originator Organization

Astellas Pharma, Inc.

Active Organization

Astellas Pharma Global Development, Inc.

Inactive Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

The purpose of this study is to evaluate the tolerability and safety profile of ASP1948 when administered as a single agent and in combination with nivolumab or pembrolizumab in participants with locally advanced (unresectable) or metastatic solid tumors; characterize the pharmacokinetic profile of ASP1948 when administered as a single agent and in combination with nivolumab or pembrolizumab and determine the recommended Phase 2 dose (RP2D) of ASP1948 when administered as a single agent and in combination with nivolumab or pembrolizumab. This study will also evaluate the antitumor effect of ASP1948 when administered as a single agent and in combination with nivolumab or pembrolizumab.

Start Date02 Jul 2018

Sponsor / Collaborator

Astellas Pharma Global Development, Inc.

[+1]

100 Clinical Results associated with ASP-1948

Login to view more data

100 Translational Medicine associated with ASP-1948

Login to view more data

100 Patents (Medical) associated with ASP-1948

Login to view more data

100 Deals associated with ASP-1948

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Locally Advanced Malignant Solid Neoplasm	Phase 1	US	Astellas Pharma Global Development, Inc.	02 Jul 2018
Locally Advanced Malignant Solid Neoplasm	Phase 1	JP	Astellas Pharma Global Development, Inc.	02 Jul 2018
Locally Advanced Malignant Solid Neoplasm	Phase 1	CA	Astellas Pharma Global Development, Inc.	02 Jul 2018
Locally Advanced Malignant Solid Neoplasm	Phase 1	IT	Astellas Pharma Global Development, Inc.	02 Jul 2018
Locally Advanced Malignant Solid Neoplasm	Phase 1	PT	Astellas Pharma Global Development, Inc.	02 Jul 2018
Locally Advanced Malignant Solid Neoplasm	Phase 1	KR	Astellas Pharma Global Development, Inc.	02 Jul 2018
Locally Advanced Malignant Solid Neoplasm	Phase 1	ES	Astellas Pharma Global Development, Inc.	02 Jul 2018
Locally Advanced Malignant Solid Neoplasm	Phase 1	TW	Astellas Pharma Global Development, Inc.	02 Jul 2018
Locally Advanced Malignant Solid Neoplasm	Phase 1	GB	Astellas Pharma Global Development, Inc.	02 Jul 2018